SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,909.68 -325.78
( -0.42%)

Global Indices

Nasdaq

53,487.79 123.39
(0.23%)

Dow Jones

7,729.14 16.38
(0.21%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nephro Care India Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

92991

INE0SUN01013

34.4868498

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEPHROCARE

24.28

136.51

EPS(TTM)

Face Value()

Div & Yield %

3.41

Back

Bal Pharma consolidated net profit rises 460.00% in the June 2026 quarter

Aug 13,2026

Net profit of Bal Pharma rose 460.00% to Rs 1.12 crore in the quarter ended June 2026 as against Rs 0.20 crore during the previous quarter ended June 2025. Sales rose 34.54% to Rs 88.62 crore in the quarter ended June 2026 as against Rs 65.87 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	88.62	65.87	35
OPM %	8.97	9.20	-
PBDT	3.92	2.73	44
PBT	1.14	0.21	443
NP	1.12	0.20	460

76,909.68 -325.78 ( -0.42%)

53,487.79 123.39 (0.23%)

7,729.14 16.38 (0.21%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)